STOCK TITAN
  1. Home
  2. Sec-filings
  3. IOVA
  4. [Form 4] IOVANCE BIOTHERAPEUTICS, INC. Insider Trading Activity

Iovance (NASDAQ: IOVA) CRO RSUs vest, 2,508 shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IOVANCE BIOTHERAPEUTICS Chief Regulatory Officer Raj K. Puri reported routine equity compensation activity. On June 1, 2026, 5,469 restricted stock units (RSUs) vested and converted into the same number of common shares. Of these, 2,508 shares were withheld by the company to cover mandatory tax obligations, which the filing specifies was not an open-market sale. After these transactions, Puri directly holds 242,191 shares of common stock and 16,409 RSUs from the referenced grant, which will continue to vest in equal quarterly installments.

Positive

  • None.

Negative

  • None.
Insider Puri Raj K.
Role Chief Regulatory Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 5,469 $0.00 --
Exercise Common Stock 5,469 $0.00 --
Tax Withholding Common Stock 2,508 $3.96 $10K
Holdings After Transaction: Restricted Stock Units — 16,409 shares (Direct, null); Common Stock — 244,699 shares (Direct, null)
Footnotes (1)
  1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
Shares withheld for taxes 2,508 shares at $3.96 Mandatory tax withholding on RSU vesting, June 1, 2026
RSUs vested 5,469 RSUs Converted into common stock on June 1, 2026
Common shares after transactions 242,191 shares Direct common stock holdings following tax withholding
Remaining RSUs from grant 16,409 RSUs Portion of March 1, 2024 grant still unvested
Restricted Stock Units financial
"Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
mandatory tax withholding requirements financial
"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs."
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
contingent right to receive one share financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Puri Raj K.
(Last)(First)(Middle)
C/O IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD, SUITE 100
(Street)
SAN CARLOS CALIFORNIA 94070
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
IOVANCE BIOTHERAPEUTICS, INC. [ IOVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Regulatory Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)06/01/2026M5,469A$0244,699D
Common Stock(2)06/01/2026F2,508D$3.96242,191(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(4)06/01/2026M5,469 (5) (5)Common stock5,469$0.0016,409(6)D
Explanation of Responses:
1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
3. Represents the common stock remaining after deducting the common stock withheld for taxes.
4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
5. The remaining RSUs will vest in equal quarterly installments.
6. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
/s/ Raj K. Puri06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did IOVA’s Chief Regulatory Officer report?

Raj K. Puri reported RSU vesting and related tax withholding. On June 1, 2026, 5,469 restricted stock units vested into common shares, and 2,508 of those shares were withheld by IOVA to satisfy mandatory tax obligations, not sold in the open market.

Did the IOVA insider sell shares in the open market in this Form 4?

No, the Form 4 does not show an open-market sale. The 2,508 shares labeled with code F were withheld by the issuer solely to meet tax withholding requirements upon RSU vesting, which the filing explicitly states is not an open-market sale of securities.

How many IOVA shares does Raj K. Puri hold after these transactions?

After these transactions, Puri holds 242,191 common shares directly. This figure reflects the remaining position after 5,469 RSUs vested into common stock and 2,508 of those shares were withheld by the company to cover mandatory tax obligations.

What happened to the restricted stock units (RSUs) reported for IOVA?

5,469 RSUs vested and converted into common stock on June 1, 2026. Each RSU represented a right to receive one share of IOVANCE common stock. The remaining 16,409 RSUs from the referenced grant will vest in equal quarterly installments over time.

How many RSUs remain outstanding for the IOVA insider after this filing?

Puri has 16,409 remaining RSUs from the March 1, 2024 grant. The filing notes this amount reflects the remainder of that specific RSU grant only and does not include any other RSUs he may hold through separate awards.